Signals LSP’s into the Global Healthcare & Lifesciences Logistics sector
AD Ports Logistics (ADPL), a subsidiary of the Logistics Cluster, AD Ports Group, and Acino, a Swiss pharmaceutical company that develops and manufactures well-proven and innovative medicines, have signed a milestone agreement for the logistics services provider to provide Acino with global freight forwarding services, inclusive of sea and air transport in the Middle East and North Africa (MENA) region.
The agreement will see ADPL leverage its fully integrated and GDP-certified end-to-end pharma cold chain capabilities to transport vital medications from Acino’s global locations of origin to markets in the MENA region.
Under the terms of the agreement, the scope of the freight forwarding services will include first mile transport, seaport and airport loading, customs clearance, and final mile logistics.
Sustainable relationship
“We look forward to building a strong and sustainable relationship with Acino and furthering our reputation as a partner for international pharma industry seeking to expand its regional market share and presence,” stressed Farook Al Zeer, Chairman, Logistics Cluster, AD Ports Group.
“Our collaboration with AD Ports Group strengthens our commitment to the MENA region, expanding outreach and improving patient access to quality healthcare,” stated Andrew Bird, Interim CEO, Acino.
“Together, we reshape healthcare delivery, paving the way for an innovative and patient-centric industry landscape,” noted Mario Ricard, Chief Operations Officer, Acino.
As the two entities are under common ownership, ADPL and Acino will synergistically leverage their collaboration within a shared network of ADQ portfolio companies, unlocking greater value and seamless integration for the benefit of their customers, a press communique concluded.
